The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
A new documentary about Ozzy Osbourne is currently in production at Paramount+. "No Escape From Now" will look behind the ...
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
While preparing for his last performance with Black Sabbath, Ozzy Osbourne discussed new documentary centered around his health battle.
A new study reveals that working memory limitations stem from learning challenges rather than storage capacity.
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered a surprising genetic connection between two very ...
Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results